Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
24
05
2020
accepted:
15
09
2020
pubmed:
24
10
2020
medline:
18
5
2021
entrez:
23
10
2020
Statut:
ppublish
Résumé
This study aimed to review the current knowledge on the utility of intraoperative fluorescence imaging in gynecologic surgery and to give evidence-based recommendations to improve the quality of care for women who undergo gynecologic surgery. A computer-based systematic review of the MEDLINE, CENTRAL, Pubmed, EMBASE, and SciSearch databases as well as institutional guidelines was performed. The time limit was set at 2000-2019. For the literature search, PRISMA guidelines were followed. A modified-Delphi method was performed in three rounds by a panel of experts to reach a consensus of conclusions and recommendations. Indocyanine green (ICG) is used primarily in gynecology for sentinel node-mapping. In endometrial and cervical cancer, ICG is a feasible, safe, time-efficient, and reliable method for lymphatic mapping, with better bilateral detection rates. Experience in vulvar cancer is more limited, with ICG used together with Tc-99 m as a dual tracer and alone in video endoscopic inguinal lymphadenectomy. In early ovarian cancer, results are still preliminary but promising. Indocyanine green fluorescence imaging also is used for ureteral assessment, allowing intraoperative ureteral visualization, to reduce the risk of ureteral injury during gynecologic surgery. For most gynecologic cancers, ICG fluorescence imaging is considered the tracer of choice for lymphatic mapping. The use of this new technology expands to a better ureteral assessment.
Sections du résumé
BACKGROUND
BACKGROUND
This study aimed to review the current knowledge on the utility of intraoperative fluorescence imaging in gynecologic surgery and to give evidence-based recommendations to improve the quality of care for women who undergo gynecologic surgery.
METHODS
METHODS
A computer-based systematic review of the MEDLINE, CENTRAL, Pubmed, EMBASE, and SciSearch databases as well as institutional guidelines was performed. The time limit was set at 2000-2019. For the literature search, PRISMA guidelines were followed. A modified-Delphi method was performed in three rounds by a panel of experts to reach a consensus of conclusions and recommendations.
RESULTS
RESULTS
Indocyanine green (ICG) is used primarily in gynecology for sentinel node-mapping. In endometrial and cervical cancer, ICG is a feasible, safe, time-efficient, and reliable method for lymphatic mapping, with better bilateral detection rates. Experience in vulvar cancer is more limited, with ICG used together with Tc-99 m as a dual tracer and alone in video endoscopic inguinal lymphadenectomy. In early ovarian cancer, results are still preliminary but promising. Indocyanine green fluorescence imaging also is used for ureteral assessment, allowing intraoperative ureteral visualization, to reduce the risk of ureteral injury during gynecologic surgery.
CONCLUSIONS
CONCLUSIONS
For most gynecologic cancers, ICG fluorescence imaging is considered the tracer of choice for lymphatic mapping. The use of this new technology expands to a better ureteral assessment.
Identifiants
pubmed: 33095359
doi: 10.1245/s10434-020-09222-x
pii: 10.1245/s10434-020-09222-x
doi:
Substances chimiques
Coloring Agents
0
Indocyanine Green
IX6J1063HV
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3266-3278Références
Schaafsma BE, Mieog JSD, Hutteman M, Van Der Vorst JR, Kuppen PJK, Löwik CWGM, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011;104:323–32.
pubmed: 21495033
pmcid: 3144993
doi: 10.1002/jso.21943
Feindel W, Yamamoto YL, Hodge CP. Intracarotid fluorescein angiography: a new method for examination of the epicerebral circulation in man. Can Med Assoc J. 1967;96:1–7.
pubmed: 4959610
pmcid: 1936876
Garski TR. Adverse reactions after administration of indocyanine green. JAMA. 1978;240:635b
doi: 10.1001/jama.240.7.635b
Reinhart MB, Huntington CR, Blair LJ, Heniford BT, Augenstein VA. Indocyanine green: historical context, current applications, and future considerations. Surg Innov. 2016;23:166–75
pubmed: 26359355
doi: 10.1177/1553350615604053
pmcid: 26359355
Ferreira H, Smith AV, Wattiez A. Application of indocyanine green in gynecology: review of the literature. Surg Technol Int. 2019;34:282–92.
pubmed: 31034577
pmcid: 31034577
Levey KA. Use of fluorescence imaging technology to identify peritoneal endometriosis: a case report of new technology. Surg Laparosc Endosc Percutan Tech. 2014;24:e63–5.
pubmed: 24686365
doi: 10.1097/SLE.0b013e31828fa28d
pmcid: 24686365
Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Cervical cancer. Version 3.2019 JNCCN J Natl Compr Cancer Netw. 2019;17:64–84.
doi: 10.6004/jnccn.2019.0001
Peiretti M, Candotti G, Buda A, Zapardiel I, Fanni D, Proto A, et al. Feasibility of hand-assisted laparoscopic sentinel node biopsy in open endometrial cancer surgery. Minim Invasive Ther Allied Technol. 2020;29(5):299–303. https://doi.org/10.1080/13645706.2019.1628063 .
doi: 10.1080/13645706.2019.1628063
pubmed: 31187667
pmcid: 31187667
Abu-Rustum NR, Angioli R, Bailey AE, Broach V, Buda A, Coriddi MR, et al. IGCS Intraoperative Technology Taskforce. Update on near-infrared imaging technology: beyond white light and the naked eye, indocyanine green and near-infrared technology in the treatment of gynecologic cancers. Int J Gynecol Cancer. 2020;30(5):670–83. https://doi.org/10.1136/ijgc-2019-001127 .
doi: 10.1136/ijgc-2019-001127
pubmed: 32234846
pmcid: 32234846
Linstone HA, Turoff M (eds). The Delphi method: techniques and applications, 1975. Retrieved 14 May 2020 at https://web.njit.edu/~turoff/pubs/delphibook/index.html .
Hsu C-C, Sandford BA. The Delphi technique: making sense of consensus. Retrieved 14 May 2020 at https://scholarworks.umass.edu/pare/vol12/iss1/10/ .
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097 .
doi: 10.1371/journal.pmed.1000097
pubmed: 19621072
pmcid: 19621072
13. Geppert B, Lönnerfors C, Bollino M, Arechvo A, Persson J. A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer. Gynecol Oncol. 2017;145:256–61.
pubmed: 28196672
doi: 10.1016/j.ygyno.2017.02.018
pmcid: 28196672
Kleppe M, Kraima AC, Kruitwagen RFPM, Van Gorp T, Smit NN, Van Munsteren JC, et al. Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer. Int J Gynecol Cancer. 2015; 25: 1405–14.
pubmed: 26397066
pmcid: 5106084
doi: 10.1097/IGC.0000000000000514
Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 1993;49:279–83.
pubmed: 8314530
doi: 10.1006/gyno.1993.1127
pmcid: 8314530
Vidal F, Leguevaque P, Motton S, Delotte J, Ferron G, Querleu D, et al. Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting. Int J Gynecol Cancer. 2013;23:1237–43.
pubmed: 23839245
doi: 10.1097/IGC.0b013e31829b1b98
pmcid: 23839245
Kim CH, Soslow RA, Park KJ, Barber EL, Khoury-Collado F, Barlin JN, et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer. 2013;23:964–70.
pubmed: 23694985
pmcid: 4079038
doi: 10.1097/IGC.0b013e3182954da8
Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: current limitations and unanswered questions. Gynecol Oncol. 2019;152:202–7.
pubmed: 30318103
doi: 10.1016/j.ygyno.2018.10.007
pmcid: 30318103
Van Der Zee AGJ, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.
pubmed: 18281661
doi: 10.1200/jco.2008.26.15_suppl.20549
pmcid: 18281661
How C, Pintilie M, Bruce JP, Hui ABY, Clarke BA, Wong P, et al. Developing a prognostic micro-RNA signature for human cervical carcinoma. PLoS One. 2015;10:e0123946.
pubmed: 25880806
pmcid: 4399941
doi: 10.1371/journal.pone.0123946
Plante M, Touhami O, Trinh X-B, Renaud M-C, Sebastianelli A, Grondin K, et al. Sentinel node-mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer: a pilot study and review of the literature. Gynecol Oncol. 2015;137:443–7.
pubmed: 25771495
doi: 10.1016/j.ygyno.2015.03.004
pmcid: 25771495
Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, et al. Sentinel node-mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes: a meta-analysis. Ann Surg Oncol. 2016;23:3749–56
pubmed: 27160526
doi: 10.1245/s10434-016-5236-x
pmcid: 27160526
How J, Gotlieb WH, Press JZ, Abitbol J, Pelmus M, Ferenczy A, et al. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node-mapping in endometrial cancer. Gynecol Oncol. 2015;137:436–42.
pubmed: 25870917
doi: 10.1016/j.ygyno.2015.04.004
pmcid: 25870917
Rozenholc A, Samouelian V, Warkus T, Gauthier P, Provencher D, Sauthier P, et al. Green versus blue: randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer. Gynecol Oncol. 2019;153:500–4.
pubmed: 30902369
doi: 10.1016/j.ygyno.2019.03.103
pmcid: 30902369
Papadia A, Zapardiel I, Bussi B, Ghezzi F, Ceccaroni M, De Ponti E, et al. Sentinel lymph node-mapping in patients with stage 1 endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99 m with blue dye versus indocyanine green fluorescent dye. J Cancer Res Clin Oncol. 2017;143:475–80.
pubmed: 27812854
doi: 10.1007/s00432-016-2297-y
pmcid: 27812854
How JA, O’Farrell P, Amajoud Z, Lau S, Salvador S, How E, et al. Sentinel lymph node-mapping in endometrial cancer: a systematic review and meta-analysis. Minerva Ginecol. 2018;70:194–214.
pubmed: 29185673
pmcid: 29185673
Sinno AK, Fader AN, Roche KL, Giuntoli RL, Tanner EJ. A comparison of colorimetric versus fluorometric sentinel lymph node-mapping during robotic surgery for endometrial cancer. Gynecol Oncol. 2014;134:281–6.
pubmed: 24882555
doi: 10.1016/j.ygyno.2014.05.022
pmcid: 24882555
Cormier B, Rozenholc AT, Gotlieb W, Plante M, Giede C. Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization of future research. Gynecol. Oncol. 2015; 138:478–85.
pubmed: 26047592
doi: 10.1016/j.ygyno.2015.05.039
pmcid: 26047592
Ballester M, Dubernard G, Lécuru F, Heitz D, Mathevet P, Marret H, et al. Detection rate and diagnostic accuracy of sentinel node biopsy in early-stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469–76.
pubmed: 21489874
doi: 10.1016/S1470-2045(11)70070-5
pmcid: 21489874
Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 2017;18:384–92.
pubmed: 28159465
doi: 10.1016/S1470-2045(17)30068-2
pmcid: 28159465
Amant F, Trum H. Sentinel lymph node-mapping in endometrial cancer: routine practice? Lancet Oncol. 2017;18:281–2.
pubmed: 28159464
doi: 10.1016/S1470-2045(17)30067-0
pmcid: 28159464
Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018;19:1394–403.
pubmed: 30143441
pmcid: 6580418
doi: 10.1016/S1470-2045(18)30448-0
Rocha A, Domínguez AM, Lécuru F, Bourdel N. Indocyanine green and infrared fluorescence in detection of sentinel lymph nodes in endometrial and cervical cancer staging: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2016;206:213–9.
pubmed: 27750179
doi: 10.1016/j.ejogrb.2016.09.027
pmcid: 27750179
Diab Y. Sentinel lymph node-mapping in cervical cancer: a comprehensive review. Int J Gynecol Cancer. 2017; 27:154–8.
pubmed: 27792042
doi: 10.1097/IGC.0000000000000853
pmcid: 27792042
Ulain Q, Han L, Wu Q, Zhao L, Wang Q, Tuo X, et al. Indocyanine green can stand alone in detecting sentinel lymph nodes in cervical cancer. J Int Med Res. 2018;46:4885–97.
pubmed: 30360672
pmcid: 6300975
doi: 10.1177/0300060518803041
Levinson KL, Mahdi H, Escobar PF. Feasibility and optimal dosage of indocyanine green fluorescence for sentinel lymph node detection using robotic single-site instrumentation: preclinical study. J Minim Invasive Gynecol. 2013;20:691–6.
pubmed: 24034538
doi: 10.1016/j.jmig.2013.03.013
pmcid: 24034538
Sociedad Española de Ginecología y Obstetricia. Oncoguía SEGO: Cáncer escamoso invasor de vulva 2016. Prog Obstet Ginecol. 2017;60(2):176–96.
Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, et al. European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer. 2017;27:832–7.
pubmed: 28441255
doi: 10.1097/IGC.0000000000000975
pmcid: 28441255
Vahrmeijer AL, Hutteman M, Van Der Vorst JR, Van De Velde CJH, Frangioni J V. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013;10:507–18.
pubmed: 23881033
pmcid: 3755013
doi: 10.1038/nrclinonc.2013.123
Crane LMA, Themelis G, Arts HJG, Buddingh KT, Brouwers AH, Ntziachristos V, et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol. 2011;120:291–5
pubmed: 21056907
doi: 10.1016/j.ygyno.2010.10.009
pmcid: 21056907
Verbeek FPR, Tummers QRJG, Rietbergen DDD, Peters AAW, Schaafsma BE, van de Velde CJH, et al. Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance. Int J Gynecol Cancer. 2015;25:1086–93
pubmed: 25768079
pmcid: 4478233
doi: 10.1097/IGC.0000000000000419
Schaafsma BE, Verbeek FPR, Peters AAW, Van Der Vorst JR, De Kroon CD, Van Poelgeest MIE, et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers. BJOG An Int J Obstet Gynaecol. 2013;120:758–64.
doi: 10.1111/1471-0528.12173
Mathéron HM, van den Berg NS, Brouwer OR, Kleinjan GH, van Driel WJ, Trum JW, et al. Multimodal surgical guidance towards the sentinel node in vulvar cancer. Gynecol Oncol. 2013;131:720–5.
pubmed: 24051219
doi: 10.1016/j.ygyno.2013.09.007
pmcid: 24051219
Buda A, Dell’Anna T, Vecchione F, Verri D, Di Martino G, Milani R. Near-infrared sentinel lymph node-mapping with indocyanine green using the VITOM II ICG Exoscope for open surgery for gynecologic malignancies. J Minim Invasive Gynecol. 2016;23:628–32.
pubmed: 26921484
doi: 10.1016/j.jmig.2016.02.015
pmcid: 26921484
Hutteman M, van der Vorst JR, Gaarenstroom KN, Peters AAW, Mieog JSD, Schaafsma BE, et al. Optimization of near-infrared fluorescent sentinel lymph node-mapping for vulvar cancer. Am J Obstet Gynecol. 2012;206:89.e1-5
Soergel P, Hertel H, Nacke AK, Klapdor R, Derlin T, Hillemanns P. Sentinel lymphadenectomy in vulvar cancer using near-infrared fluorescence from indocyanine green compared with technetium 99 m nanocolloid. Int J Gynecol Cancer. 2017;27:805–12.
pubmed: 28399034
doi: 10.1097/IGC.0000000000000996
pmcid: 28399034
Naldini A, Vizzielli G, Perrone E, Gallotta V, Scambia G. Robotic video endoscopic inguinal lymphadenectomy (R-VEIL) for vulvar cancer with sentinel node-mapping using indocyanine green and near-infrared fluorescence imaging technology. Gynecol Oncol. 2018;150:203–4.
pubmed: 29729932
doi: 10.1016/j.ygyno.2018.04.568
pmcid: 29729932
Kleppe M, Wang T, Van Gorp T, Slangen BFM, Kruse AJ, Kruitwagen RFPM. Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011; 123:610–4.
pubmed: 21982047
doi: 10.1016/j.ygyno.2011.09.013
pmcid: 21982047
Vanneuville G, Mestas D, Le Bouedec G, Veyre A, Dauplat J, Escande G, et al. The lymphatic drainage of the human ovary in vivo investigated by isotopic lymphography before and after the menopause. Surg Radiol Anat. 1991;13:221–6.
pubmed: 1754957
doi: 10.1007/BF01627990
pmcid: 1754957
Dell’Orto F, Laven P, Delle Marchette M, Lambrechts S, Kruitwagen R, Buda A. Feasibility of sentinel lymph node-mapping of the ovary: a systematic review. Int J Gynecol Cancer. 2019;29:1209–15.
pubmed: 31474589
doi: 10.1136/ijgc-2019-000606
pmcid: 31474589
Negishi H, Takeda M, Fujimoto T, Todo Y, Ebina Y, Watari H, et al. Lymphatic-mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early-stage ovarian cancer. Gynecol Oncol. 2004;94:161–6.
pubmed: 15262135
doi: 10.1016/j.ygyno.2004.04.023
pmcid: 15262135
Hassanzadeh M, Hosseini Farahabadi E, Yousefi Z, Kadkhodayan S, Zarifmahmoudi L, Sadeghi R. Lymphatic-mapping and sentinel node biopsy in ovarian tumors: a study using intraoperative Tc-99 m-phytate and lymphoscintigraphy imaging. J Ovarian Res. 2016;9:55
pubmed: 27604260
pmcid: 5013627
doi: 10.1186/s13048-016-0265-4
Nyberg RH, Korkola P, Mäenpää JU. Sentinel node and ovarian tumors: a series of 20 patients. Int J Gynecol Cancer. 2017;27:684–9.
pubmed: 28375928
doi: 10.1097/IGC.0000000000000948
pmcid: 28375928
Nyberg RH, Korkola P, Mäenpää J. Ovarian sentinel node: is it feasible? Int J Gynecol Cancer. 2011;21:568–72.
pubmed: 21436705
doi: 10.1097/IGC.0b013e318211ef75
pmcid: 21436705
Kleppe M, Brans B, Van Gorp T, Slangen BFM, Kruse AJ, Pooters INA, et al. The detection of sentinel nodes in ovarian cancer: a feasibility study. J Nucl Med. 2014;55:1799–804.
pubmed: 25332439
doi: 10.2967/jnumed.114.144329
pmcid: 25332439
Speth SCJM, Kruitwagen RFPM, Kleppe M, Pooters INA, Van Gorp T, Slangen BFM, et al. Comparison of intraoperative γ-probe imaging and postoperative SPECT/CT in detection of sentinel nodes related to the ovary. J Nucl Med. 2017;58:243–5.
pubmed: 27738006
doi: 10.2967/jnumed.116.183426
pmcid: 27738006
Angelucci M, Corrado G, Mancini E, Baiocco E, Chiofalo B, Zampa A, et al. Laparoscopic indocyanine green sentinel lymph node-mapping in early ovarian cancer a pilot study and review of the literature. Ital J Gynaecol Obstet. 2016;28:23–8.
Buda A, Passoni P, Corrado G, Bussi B, Cutillo G, Magni S, et al. Near-infrared fluorescence-guided sentinel node-mapping of the ovary with indocyanine green in a minimally invasive setting: a feasible study. J Minim Invasive Gynecol. 2017;24:165–70.
pubmed: 27670732
doi: 10.1016/j.jmig.2016.09.006
pmcid: 27670732
Lago V, Bello P, Montero B, Matute L, Padilla-Iserte P, Lopez S, et al. Clinical application of the sentinel lymph node technique in early ovarian cancer: a pilot study. Int J Gynecol Cancer. 2019;29:377–81.
pubmed: 30718316
doi: 10.1136/ijgc-2018-000049
pmcid: 30718316
Benedetti-Panici P, Greggi S, Maneschi F, Scambia G, Amoroso M, Rabitti C, et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol. 1993;51:150–4.
pubmed: 8276287
doi: 10.1006/gyno.1993.1263
pmcid: 8276287
Scambia G, Nero C, Uccella S, Vizza E, Ghezzi F, Cosentino F, et al. Sentinel-node biopsy in early-stage ovarian cancer: a prospective multicentre study (SELLY). Int J Gynecol Cancer. 2019;29:1437–9.
pubmed: 31601646
doi: 10.1136/ijgc-2019-000886
pmcid: 31601646
Cadish LA, Ridgeway BM, Shepherd JP. Cystoscopy at the time of benign hysterectomy: a decision analysis. Am J Obstet Gynecol. 2019;220:369.e1-369.e7
doi: 10.1016/j.ajog.2019.01.217
Delacroix SE, Winters JC. Urinary tract injures: recognition and management. Clin Colon Rectal Surg. 2010;23:104–12.
pubmed: 21629628
pmcid: 2967330
doi: 10.1055/s-0030-1254297
Korb ML, Huh WK, Boone JD, Warram JM, Chung TK, de Boer E, et al. Laparoscopic fluorescent visualization of the ureter with intravenous IRDye800CW. J Minim Invasive Gynecol. 2015;22:799–806..
pubmed: 25796218
pmcid: 4490072
doi: 10.1016/j.jmig.2015.03.008
Siddighi S, Yune JJ, Hardesty J. Indocyanine green for intraoperative localization of ureter. Am J Obstet Gynecol. 2014;211:436.e1-e2.
doi: 10.1016/j.ajog.2014.05.017
Gila-Bohórquez A, Gómez-Menchero J, García-Moreno JL, Suárez-Grau JM, Guadalajara-Jurado JF. Utility of indocyanine green for intraoperative localization of ureter in complex colorectal surgery. Cir Esp. 2019;97:233–4.
pubmed: 30241671
doi: 10.1016/j.ciresp.2018.07.006
pmcid: 30241671
Mandovra P, Kalikar V, Patankar R V. Real-time visualization of ureters using indocyanine green during laparoscopic surgeries: can we make surgery safer? Surg Innov. 2019;26:464–8.
pubmed: 30734638
doi: 10.1177/1553350619827152
pmcid: 30734638
Park H, Farnam RW. Novel use of indocyanine green for intraoperative, real-time localization of ureter during robot-assisted excision of endometriosis. J Minim Invasive Gynecol. 2015;22:S69
pubmed: 27679313
doi: 10.1016/j.jmig.2015.08.185
pmcid: 27679313
Cabanes M, Boria F, Hernández Gutiérrez A, Zapardiel I. Intraoperative identification of ureters using indocyanine green for gynecological oncology procedures. Int J Gynecol Cancer. 2020;30:278.
pubmed: 31722965
doi: 10.1136/ijgc-2019-000895
pmcid: 31722965
Spagnolo E, Hernández A, Pascual I, Cabanes M, López A, Zapardiel I. Bowel and ureteral assessment by indocyanine green real-time visualization during deep infiltrating endometriosis surgery. Colorectal Dis. 2020. https://doi.org/10.1111/codi.15093 .
doi: 10.1111/codi.15093
pubmed: 32337823
pmcid: 32337823
Persson J, Geppert B, Lönnerfors C, Bollino M, Måsbäck A. Description of a reproducible anatomically based surgical algorithm for detection of pelvic sentinel lymph nodes in endometrial cancer. Gynecol Oncol. 2017;147:120–5.
pubmed: 28751118
doi: 10.1016/j.ygyno.2017.07.131
pmcid: 28751118
Jewell EL, Huang JJ, Abu-Rustum NR, Gardner GJ, Brown CL, Sonoda Y, et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. Gynecol Oncol. 2014;133(2):274–7. https://doi.org/10.1016/j.ygyno.2014.02.028 .
doi: 10.1016/j.ygyno.2014.02.028
pubmed: 24582865
pmcid: 5715808
Perrone AM, Casadio P, Formelli G, Levorato M, Ghi T, Costa S, et al. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol. 2008;111:62–7.
pubmed: 18625518
doi: 10.1016/j.ygyno.2008.05.032
pmcid: 18625518
74. Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol. 2002;23:53–7
pubmed: 11876394
pmcid: 11876394
Ruiz R, Gorostidi M, Jaunarena I, Goiri C, Aguerre J, Lekuona A. Sentinel node biopsy in endometrial cancer with dual cervical and fundal indocyanine green injection. Int J Gynecol Cancer. 2018;28:139–44
pubmed: 29194192
doi: 10.1097/IGC.0000000000001151
pmcid: 29194192
Furukawa N, Oi H, Yoshida S, Shigetomi H, Kanayama S, Kobayashi H. The usefulness of photodynamic eye for sentinel lymph node identification in patients with cervical cancer. Tumori. 2010;96:936–40.
pubmed: 21388055
doi: 10.1177/548.6512
pmcid: 21388055
Crane LMA, Themelis G, Pleijhuis RG, Harlaar NJ, Sarantopoulos A, Arts HJG, et al. Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol. 2011;13:1043–9.
pubmed: 20835767
doi: 10.1007/s11307-010-0425-7
pmcid: 20835767
Van der Vorst JR, Hutteman M, Gaarenstroom KN, Peters AAW, Mieog JSD, Schaafsma BE, et al. Optimization of near-infrared fluorescent sentinel lymph node-mapping in cervical cancer patients. Int J Gynecol Cancer. 2011;21:1472–8.
pubmed: 22027751
pmcid: 3202695
doi: 10.1097/IGC.0b013e31822b451d
Rossi EC, Ivanova A, Boggess JF. Robotically assisted fluorescence-guided lymph node-mapping with ICG for gynecologic malignancies: a feasibility study. Gynecol Oncol. 2012;124:78–82.
pubmed: 21996262
doi: 10.1016/j.ygyno.2011.09.025
pmcid: 21996262
Schaafsma BE, van der Vorst JR, Gaarenstroom KN, Peters AAW, Verbeek FPR, de Kroon CD, et al. Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node-mapping of cervical cancer. Gynecol Oncol. 2012;127:126–30.
pubmed: 22796548
pmcid: 3432653
doi: 10.1016/j.ygyno.2012.07.002
Imboden S, Papadia A, Nauwerk M, McKinnon B, Kollmann Z, Mohr S, et al. A comparison of radiocolloid and indocyanine green fluorescence imaging, sentinel lymph node-mapping in patients with cervical cancer undergoing laparoscopic surgery. Ann Surg Oncol. 2015;22:4198–203.
pubmed: 26122376
pmcid: 4644188
doi: 10.1245/s10434-015-4701-2
Buda A, Di Martino G, Vecchione F, Bussi B, Dell’Anna T, Palazzi S, et al. Optimizing strategies for sentinel lymph node-mapping in early-stage cervical and endometrial cancer: comparison of real-time fluorescence with indocyanine green and methylene blue. Int J Gynecol Cancer. 2015;25:1513–8.
pubmed: 26397069
doi: 10.1097/IGC.0000000000000526
pmcid: 26397069
Buda A, Papadia A, Zapardiel I, Vizza E, Ghezzi F, De Ponti E, et al. From conventional radiotracer Tc-99(m) with blue dye to indocyanine green fluorescence: a comparison of methods towards optimization of sentinel lymph node-mapping in early-stage cervical cancer for a laparoscopic approach. Ann Surg Oncol. 2016;23:2959–65.
pubmed: 27126631
doi: 10.1245/s10434-016-5227-y
pmcid: 27126631
Buda A, Crivellaro C, Elisei F, Di Martino G, Guerra L, De Ponti E, et al. Impact of indocyanine green for sentinel lymph node-mapping in early-stage endometrial and cervical cancer: comparison with conventional radiotracer 99mTc and/or blue dye. Ann Surg Oncol. 2016;23:2183–91.
pubmed: 26714944
doi: 10.1245/s10434-015-5022-1
pmcid: 26714944
Beavis AL, Salazar-Marioni S, Sinno AK, Stone RL, Fader AN, Santillan-Gomez A, et al. Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer. Gynecol Oncol. 2016;143:302–6.
pubmed: 27526991
pmcid: 5576021
doi: 10.1016/j.ygyno.2016.08.236
Di Martino G, Reato C, Verri D, Dell’Orto F, Buda A. Laparoscopic typical and atypical locations of sentinel node-mapping with indocyanine green: comparison of 2 near-infrared fluorescence systems. J Minim Invasive Gynecol. 2018;25:384–5.
pubmed: 28939481
doi: 10.1016/j.jmig.2017.09.011
pmcid: 28939481
Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, et al. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017;145:96–101
pubmed: 28188015
pmcid: 5873580
doi: 10.1016/j.ygyno.2017.02.005
Kim JH, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, et al. The efficacy of sentinel lymph node-mapping with indocyanine green in cervical cancer. World J Surg Oncol. 2018;16:52.
pubmed: 29523141
pmcid: 5845382
doi: 10.1186/s12957-018-1341-6
Buda A, Papadia A, Di Martino G, Imboden S, Bussi B, Guerra L, et al. Real-time fluorescent sentinel lymph node-mapping with indocyanine green in women with previous conization undergoing laparoscopic surgery for early invasive cervical cancer: comparison with radiotracer ± blue dye. J Minim Invasive Gynecol. 2018;25:455–60.
pubmed: 29032256
doi: 10.1016/j.jmig.2017.10.002
pmcid: 29032256
Soergel P, Kirschke J, Klapdor R, Derlin T, Hillemanns P, Hertel H. Sentinel lymphadenectomy in cervical cancer using near-infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid. Lasers Surg Med. 2018;50:994–1001.
pubmed: 29968916
doi: 10.1002/lsm.22999
pmcid: 29968916
Papadia A, Morosi C, Wang J, Gasparri ML, Rau T, Ghezzi F, et al. SLN mapping in early-stage cervical cancer as a minimal-invasive triaging tool for multimodal treatment. Eur J Surg Oncol. 2019;45(4):679–83.
pubmed: 30732972
doi: 10.1016/j.ejso.2019.01.184
pmcid: 30732972
Bedyńska M, Szewczyk G, Klepacka T, Sachadel K, Maciejewski T, Szukiewicz D, et al. Sentinel lymph node-mapping using indocyanine green in patients with uterine and cervical neoplasms: restrictions of the method. Arch Gynecol Obstet. 2019;299:1373–84.
pubmed: 30762108
pmcid: 6475506
doi: 10.1007/s00404-019-05063-6